MedPacto Inc banner

Intrinsic Value

Is MedPacto Inc undervalued or overvalued?

See the intrinsic value estimate for MedPacto Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.

Do our valuations actually work? See backtest results .

MedPacto Inc Intrinsic Value
LOCKED
Unlock
Today vs. history

MedPacto Inc looks undervalued.
But is it cheap by its own standards?

See how today’s valuation compares with MedPacto Inc’s past valuations and how the stock performed after similar periods.

See what happened next Free account required
Monitor MedPacto Inc
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value
Get notified when the price drops into your buy zone
Intrinsic Value Locked
Margin of Safety 20% Locked
Current Price ₩3 050
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to MedPacto Inc

Fundamental Analysis

What MedPacto Does

Biotechnology Health Care

MedPacto Inc is a South Korean biopharmaceutical company that develops drug candidates for cancer and other serious diseases. Its work is centered on researching new medicines, testing them in preclinical and clinical studies, and turning promising molecules into treatments that can be licensed or sold if they succeed.

Headquarters
Korea KR
Employees
53
IPO date
Dec 19, 2019
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
MedPacto Inc

Wall St Price Targets

Capital Returns

Buyback Yield
LOCKED
Debt Paydown Yield
LOCKED

Competitive Landscape

What is the Intrinsic Value of one MedPacto Inc stock?

The intrinsic value for MedPacto Inc (235980) under the Base Case is hidden KRW.

Is MedPacto Inc stock undervalued or overvalued?

Compared with the current market price of 3 050 KRW, the stock appears hidden.

Back to Top